author-photo

Oliver Findling

University of Bern

56

Papers

1321

Citations

Citation Trend

Filter By

Papers (41) Sort By

Journal Conference Others

Intrathecal Immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis.

2021 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (20)
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study

2020 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (2)
Abstract WP225: Fetal-Type Posterior Cerebral Artery: A Not So Benign Anatomical Variant?

2020 Stroke
Show All
- Source
- Cite
- Save
Citations (0)
Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz

2019
Show All
- Source
- Cite
- Save
Citations (0)
Particularités de l’immunothérapie de la sclérose en plaques en Suisse

2019 Forum Médical Suisse
Show All
- Source
- Cite
- Save
Citations (1)
A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score

2019 Neurology
Show All
- Source
- Cite
- Save
Citations (18)
Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary:

2019
Show All
- Source
- Cite
- Save
Citations (4)
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod:

2018 Therapeutic Advances in Neurological Disorders
Show All
- Source
- Cite
- Save
Citations (9)
Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis.

2018 European Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (9)